embecta to Participate in Investor Events
Embecta (Nasdaq: EMBC), a medical supplies company specializing in insulin delivery, has announced its participation in two major healthcare investor conferences in September 2025.
At the 2025 Wells Fargo Healthcare Conference on September 4, management will host a fireside chat at 3:00 p.m. EDT and conduct one-on-one investor meetings at the Encore Boston Harbor Hotel. The company will also participate in the 2025 Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, hosting one-on-one investor meetings at the Sheraton New York Times Square.
Embecta (Nasdaq: EMBC), azienda di dispositivi medici specializzata nella somministrazione di insulina, ha comunicato la sua partecipazione a due importanti conferenze per investitori nel settore sanitario previste per settembre 2025.
Il 4 settembre 2025, alla Wells Fargo Healthcare Conference 2025, il management terrà una fireside chat alle 3:00 p.m. EDT e svolgerà incontri one-to-one con investitori presso l'Encore Boston Harbor Hotel. Inoltre, il 9 settembre 2025 parteciperà alla Morgan Stanley 23rd Annual Global Healthcare Conference 2025, con incontri one-to-one programmati al Sheraton New York Times Square.
Embecta (Nasdaq: EMBC), una compañía de suministros médicos especializada en la administración de insulina, ha anunciado su participación en dos importantes conferencias para inversores del sector salud en septiembre de 2025.
El 4 de septiembre de 2025, en la Wells Fargo Healthcare Conference 2025, la dirección ofrecerá una charla tipo "fireside chat" a las 3:00 p.m. EDT y celebrará reuniones individuales con inversores en el Encore Boston Harbor Hotel. Además, el 9 de septiembre de 2025 participará en la Morgan Stanley 23rd Annual Global Healthcare Conference 2025, con reuniones one-to-one en el Sheraton New York Times Square.
Embecta (Nasdaq: EMBC), 인슐린 전달 장치 전문 의료용품 회사는 2025년 9월에 열리는 두 건의 주요 헬스케어 투자자 콘퍼런스에 참여한다고 발표했습니다.
2025 Wells Fargo Healthcare Conference는 9월 4일로, 경영진은 오후 3:00 p.m. EDT에 파이어사이드 채팅을 진행하고 Encore Boston Harbor Hotel에서 일대일 투자자 미팅을 실시합니다. 또한 2025 Morgan Stanley 23rd Annual Global Healthcare Conference에는 9월 9일 Sheraton New York Times Square에서 일대일 미팅에 참여할 예정입니다.
Embecta (Nasdaq: EMBC), société de fournitures médicales spécialisée dans l'administration d'insuline, a annoncé sa participation à deux grandes conférences pour investisseurs du secteur de la santé en septembre 2025.
Le 4 septembre 2025, lors de la Wells Fargo Healthcare Conference 2025, la direction tiendra un fireside chat à 3:00 p.m. EDT et mènera des réunions individuelles avec des investisseurs à l'Encore Boston Harbor Hotel. Par ailleurs, le 9 septembre 2025, la société participera à la Morgan Stanley 23rd Annual Global Healthcare Conference 2025, où elle organisera des meetings one-to-one au Sheraton New York Times Square.
Embecta (Nasdaq: EMBC), ein Medizintechnikunternehmen, das sich auf Insulinverabreichung spezialisiert hat, kündigte seine Teilnahme an zwei großen Healthcare-Investorenkonferenzen im September 2025 an.
Am 4. September 2025 wird das Management auf der 2025 Wells Fargo Healthcare Conference um 3:00 p.m. EDT ein Fireside-Chat geben und Einzelgespräche mit Investoren im Encore Boston Harbor Hotel führen. Zudem nimmt das Unternehmen am 9. September 2025 an der 2025 Morgan Stanley 23rd Annual Global Healthcare Conference teil und führt Eins-zu-eins-Gespräche im Sheraton New York Times Square.
- None.
- None.
PARSIPPANY, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:
2025 Wells Fargo Healthcare Conference
- Management will host a fireside session on Thursday, September 4, 2025, at 3:00 p.m. EDT and one-on-one investor meetings throughout the day at the Encore Boston Harbor Hotel, Boston.
2025 Morgan Stanley 23rd Annual Global Healthcare Conference
- Management will host one-on-one investor meetings on Tuesday, September 9, 2025, at Sheraton New York Times Square, New York City.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
FAQ
When is Embecta (EMBC) presenting at the Wells Fargo Healthcare Conference 2025?
Where will Embecta (EMBC) host investor meetings during the Morgan Stanley Healthcare Conference?
What investor conferences is Embecta (EMBC) attending in September 2025?
What type of company is Embecta (EMBC)?
